ACTRN12624000889550尚未招募Unknown
Evaluating the effects of personalised alpha-tACS on alpha power in participants with post-traumatic stress disorder (PTSD)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Aged between 18-80 years of age
- •Clinician-Administered PTSD Scale (CAPS-5) total score of moderate-severe (greater than or equal to 20)
- •No change or initiation of new medication (antidepressant or other psychoactive) in the four weeks prior to screening
- •Demonstrated capacity to give informed consent
排除标准
- •Inability to provide informed consent
- •Medically unstable
- •Concomitant active neurological disorder
- •Individuals who are pregnant or breastfeeding
- •Active suicidal intent
- •Any psychotic disorder or current active psychotic symptoms
- •Meets criteria for current DSM 5 alcohol or substance dependence
- •Borderline personality disorder judged by an investigator to prevent appropriate engagement in the study
- •Individuals who have intracranial implants
- •Another AXIS I or II disorder judged to impact on the likelihood of response to treatment
研究者
相似试验
已完成
不适用
Study for evaluating efficacy and safety of TACE with miriplatin in the treatment of patients with hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000003987Tokai University School of Medicine, Department of Internal Medicine, Division of Gastroenterology40
已完成
不适用
Retrospective study to determine the effects of acetabular fractureExamination of the quality of life after an acetabular fractureS32.4Fracture of acetabulumDRKS00004762Berufsgenossenschaftliche UnfallklinikKlinik für Unfall- und Wiederherstellungschirurgie derEberhard-Karls-Universität Tübingen58
进行中（未招募）
Unknown
Evaluation of transcranial alternating current stimulation effect by advanced neurocomputational methods in schizophreniaMental and Behavioural DisordersSchizophreniaISRCTN56047723ational Institute of Mental Health60
已完成
不适用
A Comparative study of efficacy and safety of Tapcom combination ophthalmic solution and Xalacom combination eye drops.primary open angle glaucoma or ocular hypertensionJPRN-UMIN000023862Santen Pharmaceutical Co., Ltd.150
进行中（未招募）
1 期
AMSA2020: A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined with Cytarabine administered as post-remission therapy to elderly patients with acute myeloid leukemia in first remission”elderly patients (> = 60 years) with Acute Myeloid LeukemiaMedDRA version: 21.1Level: PTClassification code: 10000880Term: Acute myeloid leukaemia Class: 100000004864CTIS2022-502392-37-00French Innovative Leukemia Organization114